4 volumes ; 24 cm "The material in this book is an abstract of, and index to, information reported by the National Society Daughters of the American Revolution and published in their Annual Reports to ...

Abstract Submission Launches. LATE MAY 2025 Registration and Housing Websites Open. JUNE 10, 2025 AT 11:59 PM (ET) Abstract Submission Deadline. LATE JULY 2025 Abstract notifications sent to first ...

Abstract Change/Withdrawal Deadline: August 25, 2025, at 12:00 PM (ET) Abstract Eligibility. As you prepare your submission to the Meeting, please make note of the following details: Summaries of new, ...

Abstract artist Ketki Fadnis echoes this sentiment, highlighting how abstract art speaks not just to the eyes, but to the soul. “The beauty of abstract art lies in its subjectivity," she explains.

Abstract Background. Women receiving endocrine therapy for hormone receptor (HR)–positive breast cancer or its prevention among those at high risk for breast cancer commonly have vasomotor symptoms.

The abstract ‘Eating Rate has Sustained Effects on Energy Intake from Ultra-Processed Diets: A Two-Week Ad Libitum Dietary Randomized Controlled Trial’ by Ciarán G. Forde et al. was presented at the ...

Vepdegestrant is an oral proteolysis-targeting chimera (PROTAC) estrogen receptor (ER) degrader that directly harnesses the ubiquitin–proteasome system.In this phase 3, open-label, randomized ...

Of the 7763 records identified, nine reviews were eligible for inclusion of the umbrella review. One review was judged to be of moderate quality, while the others were either low (n = 3) or critically ...

Meeting Abstract: 2025 ASCO Annual Meeting I. Free access. Gastrointestinal Cancer—Colorectal and Anal. May 28, 2025. Share on. ctDNA-guided adjuvant chemotherapy escalation in stage III colon cancer: ...

Meeting Abstract: 2025 ASCO Annual Meeting I. Free access. Melanoma/Skin Cancers. May 28, 2025. Share on. DREAMseq: A phase III trial of treatment sequences in BRAFV600-mutant (m) metastatic melanoma ...